CausalSentinel

Protein Dossier — PLA2G2A (Phospholipase A2, membrane associated)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Cancer code self-reported: prostate cancer 0.0829 0.0305 0.00649 Wald ratio 1 cis NA
Non-cancer illness code self-reported: vitiligo 0.333 0.125 0.00762 Wald ratio 1 cis NA
Fasting glucose 0.0098 0.00382 0.0103 Wald ratio 1 cis NA
Non-cancer illness code self-reported: osteoarthritis -0.0225 0.00968 0.0202 Wald ratio 1 cis NA
Percent emphysema -0.0478 0.0208 0.0213 Wald ratio 1 cis NA
Cancer code self-reported: basal cell carcinoma 0.0633 0.0277 0.0224 Wald ratio 1 cis NA
Fractured or broken bones in last 5 years -0.0194 0.009 0.031 Wald ratio 1 cis NA
Non-cancer illness code self-reported: joint disorder -0.0978 0.0456 0.0321 Wald ratio 1 cis NA
Diagnoses - main ICD10: G47 Sleep disorders 0.073 0.0343 0.0334 Wald ratio 1 cis NA
Bipolar disorder 0.0586 0.0294 0.0463 Wald ratio 1 cis NA
Diagnoses - main ICD10: I83 Varicose veins of lower extremities 0.0375 0.019 0.0488 Wald ratio 1 cis NA
Height 0.00706 0.00363 0.0517 Wald ratio 1 cis NA
…and 68 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2692_74_2 NPS-PLA2 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

36 association rows across 17 traits (34 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Phospholipase A2, membrane associated levels 2e-1000 rs11573156 6 GCST90248834 no MR -> candidate analysis
Group IIA secretory phospholipase A2 levels in individuals w 5e-472 rs11573156 3 GCST008260 no MR -> candidate analysis
Phospholipase A2, membrane associated levels (PLA2G2A.2692.7 2e-384 rs11573156 2 GCST90242257 no MR -> candidate analysis
Serum levels of protein PLA2G2A 1e-292 rs11573156 2 GCST90088020 no MR -> candidate analysis
PLA2G2A protein levels 5e-265 rs1588050 11 GCST90470247 no MR -> candidate analysis
Blood protein levels 2e-111 rs4744 1 GCST006585 no MR -> candidate analysis
A0A3B3IRX2;PA2GA protein level (protein group normalized int 2e-38 rs2307246 1 GCST90570761 no MR -> candidate analysis
Protein levels in obesity 3e-26 rs10732279 1 GCST010196 no MR -> candidate analysis
Brevican core protein protein levels (SomaScan ID:2692-74) 4e-23 rs11573156 1 GCST90440967 no MR -> candidate analysis
CXCL14 protein levels 3e-17 rs11573156 1 GCST90468927 no MR -> candidate analysis
Circulating CCDC80 levels 1e-16 rs11573156 1 GCST90860352 no MR -> candidate analysis
LECT2 protein levels 4e-16 rs11573156 1 GCST90469751 no MR -> candidate analysis
…and 5 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 400 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
familial colorectal cancer 0.547 established (curated) no MR -> candidate analysis
ectropion 0.448 common-variant locus no MR -> candidate analysis
entropion 0.448 common-variant locus no MR -> candidate analysis
breast adenosis 0.096 common-variant locus no MR -> candidate analysis

Of the 4 rows above, 4 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 2 known modulators (Phospholipase A2, membrane associated)
gnomAD constraint pLI=0.076, LOEUF=1.06 — LoF-tolerant
GWAS Catalog 60 unique SNPs / 116 rows
ClinVar 55 records; 3 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance